281.1 ð é«åžçç
281.1.0.1 ð äžé éé»
281.1.0.1.1 Anatomy + Basics
281.1.0.1.2 Aneurysms
281.1.0.1.2.1 Thoracic Aortic Aneurysm (TAA)
- Localization:
- Ascending (60%)
- Arch (10%)
- Descending (30%)
- Etiology:
- Atherosclerotic (esp descending) â most common
- Cystic medial degeneration (Marfan, Loeys-Dietz, vEDS, bicuspid AV)
- Inflammatory (Takayasu, GCA, IgG4)
- Mycotic / infectious (Salmonella, Staph)
- Traumatic (deceleration â aortic isthmus)
- Asymptomatic until complications
- Symptoms when large/dissecting: chest/back pain, dyspnea, hoarseness (RLN compression), Horner, dysphagia, hemoptysis
281.1.0.1.2.2 Abdominal Aortic Aneurysm (AAA)
- Definition: aortic diameter > 3 cm (or > 1.5Ã normal)
- Most common location: infrarenal
- Etiology: atherosclerotic + degenerative (most), genetic (familial), inflammatory, mycotic
- Risk factors: smoking (#1, 4-7x), age, male, FHx, HTN, atherosclerosis
- Often asymptomatic until rupture
- Triad of ruptured AAA: hypotension + back pain + pulsatile abdominal mass (50% have all three)
281.1.0.1.2.3 Screening
- AAA: One-time US screening for men 65-75 with smoking history (USPSTF Class B)
- Women with risk factors: individualized
- First-degree relatives of AAA patients: screen
- TAA: imaging screening for Marfan, Loeys-Dietz, vEDS, BAV; family history; coarctation
281.1.0.1.2.4 Workup
- Ultrasound for AAA (cheap, no radiation, screening)
- CTA: gold standard for TAA + AAA, surgical planning
- MRA: alternative if CKD or younger
- Echocardiogram (TTE/TEE): aortic root, ascending aorta
281.1.0.1.2.5 Treatment
- Medical:
- Smoking cessation (slows growth)
- BP control < 130/80 (ACEi/ARB, β-blocker; β-blocker historically used, less clear benefit)
- Statin
- Avoid heavy lifting
- Treat connective tissue disorder (losartan in Marfan)
- Surveillance:
- AAA 3-4 cm: every 2-3 years
- AAA 4-5 cm: every 12 months
- AAA 5-5.4 cm: every 6 months
- AAA > 5.5 cm: surgical consult
281.1.0.1.2.6 Surgical Indications
- AAA:
- Diameter ⥠5.5 cm â, ⥠5.0 cm â
- Rapid growth ⥠0.5 cm/year
- Symptomatic (pain)
- Rupture (emergency)
- TAA (Ascending):
- ⥠5.5 cm (general)
- ⥠5.0 cm with Marfan, BAV
- ⥠4.5 cm with FHx of dissection at smaller size
- ⥠4.0 cm for Loeys-Dietz, vEDS
- Rapid growth ⥠0.5 cm/year
- Coexisting AV disease requiring surgery
- TAA (Descending):
- ⥠5.5-6.0 cm
- Symptomatic
- TEVAR often first-line
281.1.0.1.2.7 Repair Options
- Open surgery: gold standard for ascending TAA, complex anatomy
- EVAR (endovascular AAA repair): less invasive, â early survival, â early morbidity (but â re-intervention long-term â EVAR-1, OVER)
- TEVAR (thoracic EVAR): for descending TAA, type B dissection
- Branched / fenestrated grafts: for visceral artery involvement
281.1.0.1.3 Acute Aortic Syndromes (AAS)
281.1.0.1.3.1 Spectrum
- Aortic dissection (most common)
- Intramural hematoma (IMH) â variant
- Penetrating atherosclerotic ulcer (PAU) â variant
- Ruptured / contained leak aneurysm
281.1.0.1.3.2 Aortic Dissection
Mechanism: - Intimal tear â blood enters media â propagates â creates true + false lumen - Compromise of branch vessels â end-organ ischemia - Risk: HTN (most), Marfan, BAV, pregnancy, cocaine, trauma, vasculitis
Classification â Stanford: - Type A: involves ascending aorta (60%) - Type B: confined to descending aorta (40%)
Classification â DeBakey: - I: ascending + descending - II: ascending only - III: descending only
Clinical Presentation: - Sudden severe tearing chest pain radiating to back - BP differential between arms > 20 mmHg - New murmur of aortic regurgitation (Type A) - Neurologic deficits (carotid involvement) - Limb ischemia (subclavian, iliac) - Cardiac tamponade (rupture into pericardium â Type A) - Hemothorax (rupture) - Renal/mesenteric ischemia - Spinal cord ischemia
Workup: - CT angiography (gold standard, fastest) - TEE (excellent for Type A, requires sedation) - MRA (more time, less practical acute) - D-dimer (high NPV, useful for low-risk rule-out) - AAS detection risk score (ADD-RS): 3 features (high-risk conditions, pain features, exam findings); score 0-3, ⥠1 suggests AAS
Treatment:
Type A: - EMERGENCY SURGERY (50% 30-day mortality untreated) - Replace ascending aorta ± valve sparing or AVR + root replacement - Bentall procedure if root involvement - Hybrid approach (frozen elephant trunk) for arch + descending involvement
Type B: - Uncomplicated: medical management - β-blocker FIRST (esmolol, then labetalol) - SBP < 120, HR < 60 within 10-30 min - Pain control - Avoid vasodilator alone (reflex tachy worsens dissection) - Complicated: - Ongoing pain - Malperfusion (renal, mesenteric, limb, spinal cord) - Rupture / impending rupture - Aneurysmal dilation - TEVAR preferred (INSTEAD-XL, ADSORB trials)
281.1.0.1.4 Inflammatory + Infectious Aortic Disease
281.1.0.1.4.1 Takayasu Arteritis
- Large vessel vasculitis
- Young Asian women
- Aorta + main branches (subclavian, carotid, renal)
- âPulseless diseaseâ
- Treatment: glucocorticoids, methotrexate, biologics
- See Ch295 for vasculitis
281.1.0.1.5 Genetic Aortopathies
281.1.0.1.5.1 Marfan Syndrome
- AD, FBN1 mutation â fibrillin-1 abnormal â TGF-β signaling dysregulated
- Skeletal: tall, arachnodactyly, pectus, scoliosis, joint laxity
- Cardiovascular: aortic root dilation + dissection, MV prolapse
- Ocular: ectopia lentis (upward), myopia
- Diagnosis: Ghent criteria
- Treatment:
- Losartan + β-blocker (slows aortic growth â COMPARE, MEND, AIMS)
- Aortic surgery at root ⥠5.0 cm (some 4.5 cm if family hx)
- Avoid contact sports + isometric exercise
281.1.0.1.5.2 Loeys-Dietz Syndrome
- TGFBR1/2, SMAD3, TGFB2/3 mutations
- Aggressive aortopathy with dissection at smaller sizes (⥠4.0 cm threshold)
- Cleft palate, hypertelorism, arterial tortuosity
- Bifid uvula characteristic
- Higher dissection risk than Marfan
281.1.0.1.5.3 Vascular Ehlers-Danlos (vEDS)
- COL3A1 mutation (type III collagen)
- Spontaneous arterial rupture, bowel rupture, uterine rupture
- Translucent skin, easy bruising
- Avoid catheterization / surgery if possible
- Celiprolol (β-blocker) â BBEST trial reduced events
281.1.0.2 𩺠åºé鿥
- AAA screening: 65-75 ç·æ§åžèžè äžæ¬¡ USïŒUSPSTF Class BïŒ
- AAA repair: â ⥠5.5 cm, â ⥠5.0 cm, growth ⥠0.5 cm/yr
- TAA repair: ⥠5.5 cmïŒæ®éïŒïŒâ¥ 5.0 cmïŒMarfan, BAVïŒïŒâ¥ 4.0-4.5 cmïŒLoeys-DietzïŒ
- Type A dissection: EMERGENCY surgery
- Type B dissection: medical firstïŒesmolol â nicardipine, SBP < 120, HR < 60ïŒïŒcomplicated â TEVAR
- D-dimer + ADD-RS: çšæŒäœé¢šéª AAS rule-out